Trade Valneva SE - VLA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.021388% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.000834% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | France | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Valneva SE ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
| Prev. Close* | 5.5 |
| Open* | 5.55 |
| 1-Year Change* | -3.14% |
| Day's Range* | 5.52 - 5.62 |
| 52 wk Range | 3.95-8.78 |
| Average Volume (10 days) | 218.22K |
| Average Volume (3 months) | 7.08M |
| Market Cap | 880.60M |
| P/E Ratio | -100.00K |
| Shares Outstanding | 138.22M |
| Revenue | 372.96M |
| EPS | -1.24 |
| Dividend (Yield %) | N/A |
| Beta | 0.58 |
| Next Earnings Date | Sep 21, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 29, 2023 | 5.52 | 0.02 | 0.36% | 5.50 | 5.63 | 5.39 |
| Sep 28, 2023 | 5.50 | 0.03 | 0.55% | 5.47 | 5.55 | 5.43 |
| Sep 27, 2023 | 5.50 | -0.06 | -1.08% | 5.56 | 5.69 | 5.49 |
| Sep 26, 2023 | 5.53 | -0.16 | -2.81% | 5.69 | 5.69 | 5.48 |
| Sep 25, 2023 | 5.76 | -0.42 | -6.80% | 6.18 | 6.25 | 5.68 |
| Sep 22, 2023 | 5.84 | 0.01 | 0.17% | 5.83 | 5.97 | 5.79 |
| Sep 21, 2023 | 5.97 | -0.21 | -3.40% | 6.18 | 6.42 | 5.90 |
| Sep 20, 2023 | 6.20 | 0.27 | 4.55% | 5.93 | 6.21 | 5.93 |
| Sep 19, 2023 | 6.01 | 0.00 | 0.00% | 6.01 | 6.07 | 5.89 |
| Sep 18, 2023 | 6.05 | 0.00 | 0.00% | 6.05 | 6.27 | 6.04 |
| Sep 15, 2023 | 6.25 | -0.02 | -0.32% | 6.27 | 6.52 | 6.23 |
| Sep 14, 2023 | 6.28 | 0.14 | 2.28% | 6.14 | 6.29 | 6.09 |
| Sep 13, 2023 | 6.13 | -0.05 | -0.81% | 6.18 | 6.21 | 6.09 |
| Sep 12, 2023 | 6.21 | -0.12 | -1.90% | 6.33 | 6.35 | 6.16 |
| Sep 11, 2023 | 6.34 | 0.08 | 1.28% | 6.26 | 6.40 | 6.24 |
| Sep 8, 2023 | 6.27 | -0.02 | -0.32% | 6.29 | 6.34 | 6.22 |
| Sep 7, 2023 | 6.32 | 0.05 | 0.80% | 6.27 | 6.46 | 6.27 |
| Sep 6, 2023 | 6.34 | 0.14 | 2.26% | 6.20 | 6.44 | 6.20 |
| Sep 5, 2023 | 6.49 | 0.10 | 1.56% | 6.39 | 6.54 | 6.39 |
| Sep 4, 2023 | 6.44 | 0.07 | 1.10% | 6.37 | 6.55 | 6.25 |
Valneva SE Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 361.303 | 348.086 | 110.321 | 126.196 | 113.035 |
| Revenue | 361.303 | 348.086 | 110.321 | 126.196 | 113.035 |
| Cost of Revenue, Total | 324.441 | 182.22 | 46.902 | 49.968 | 44.448 |
| Gross Profit | 36.862 | 165.866 | 63.419 | 76.228 | 68.587 |
| Total Operating Expense | 474.746 | 409.476 | 165.441 | 127.007 | 106.774 |
| Selling/General/Admin. Expenses, Total | 56.499 | 70.761 | 45.171 | 42.277 | 37.84 |
| Research & Development | 101.322 | 168.583 | 61.354 | 36.783 | 24.291 |
| Depreciation / Amortization | 4.9 | 5.4 | 4.9 | 4.464 | 4.331 |
| Unusual Expense (Income) | 0.038 | 5.742 | 26.41 | 0.092 | 0.007 |
| Other Operating Expenses, Total | -12.454 | -23.23 | -19.296 | -6.577 | -4.143 |
| Operating Income | -113.443 | -61.39 | -55.12 | -0.811 | 6.261 |
| Interest Income (Expense), Net Non-Operating | -31.108 | -8.281 | -10.182 | -0.059 | -2.909 |
| Other, Net | -0.264 | -0.308 | -0.001 | ||
| Net Income Before Taxes | -144.815 | -69.979 | -65.302 | -0.87 | 3.351 |
| Net Income After Taxes | -143.279 | -73.425 | -64.393 | -1.744 | 3.263 |
| Net Income Before Extra. Items | -143.279 | -73.425 | -64.393 | -1.744 | 3.263 |
| Net Income | -143.279 | -73.425 | -64.393 | -1.744 | 3.263 |
| Income Available to Common Excl. Extra. Items | -143.279 | -73.425 | -64.393 | -1.744 | 3.264 |
| Income Available to Common Incl. Extra. Items | -143.279 | -73.425 | -64.393 | -1.744 | 3.264 |
| Diluted Net Income | -143.279 | -73.425 | -64.393 | -1.744 | 3.264 |
| Diluted Weighted Average Shares | 115.474 | 97.6193 | 90.7572 | 91.7443 | 81.6002 |
| Diluted EPS Excluding Extraordinary Items | -1.24079 | -0.75216 | -0.70951 | -0.01901 | 0.04 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
| Diluted Normalized EPS | -1.10971 | -0.71392 | -0.51936 | -0.01836 | 0.04008 |
| Total Adjustments to Net Income | 0.001 | ||||
| Dilution Adjustment | 0 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total revenue | 33.508 | 268.079 | 156.678 | 93.224 | 21.847 |
| Revenue | 33.508 | 268.079 | 156.678 | 93.224 | 21.847 |
| Cost of Revenue, Total | 20.48 | 152.962 | 31.247 | 171.479 | 13.86 |
| Gross Profit | 13.028 | 115.117 | 125.431 | -78.255 | 7.987 |
| Total Operating Expense | 50.082 | 231.112 | 63.361 | 243.634 | 40.269 |
| Selling/General/Admin. Expenses, Total | 19.024 | 33.704 | 12.488 | 24.095 | 7.804 |
| Research & Development | 14.065 | 53.039 | 23.502 | 51.883 | 20.689 |
| Other Operating Expenses, Total | -3.487 | -8.585 | -3.876 | -3.869 | -2.084 |
| Operating Income | -16.574 | 36.967 | 93.317 | -150.41 | -18.422 |
| Interest Income (Expense), Net Non-Operating | -1.673 | -12.531 | -21.007 | -18.577 | -7.117 |
| Other, Net | -0.029 | -0.235 | |||
| Net Income Before Taxes | -18.247 | 24.407 | 72.31 | -169.222 | -25.539 |
| Net Income After Taxes | -18.127 | 28.214 | 72.418 | -171.493 | -26.041 |
| Net Income Before Extra. Items | -18.127 | 28.214 | 72.418 | -171.493 | -26.041 |
| Net Income | -18.127 | 28.214 | 72.418 | -171.493 | -26.041 |
| Income Available to Common Excl. Extra. Items | -18.127 | 28.214 | 72.418 | -171.493 | -26.041 |
| Income Available to Common Incl. Extra. Items | -18.127 | 28.214 | 72.418 | -171.493 | -26.041 |
| Diluted Net Income | -18.127 | 28.214 | 72.418 | -171.493 | -26.041 |
| Diluted Weighted Average Shares | 139.438 | 122.408 | 105.991 | 108.54 | 108.504 |
| Diluted EPS Excluding Extraordinary Items | -0.13 | 0.23049 | 0.68325 | -1.58 | -0.24 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Diluted Normalized EPS | -0.13 | 0.33638 | 0.68325 | -1.55996 | -0.24 |
| Unusual Expense (Income) | -0.008 | 0.046 | |||
| Total Adjustments to Net Income |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Current Assets | 424.66 | 585.832 | 308.427 | 129.162 | 125.972 |
| Cash and Short Term Investments | 286.532 | 346.642 | 204.394 | 64.439 | 77.084 |
| Cash | 286.533 | 346.642 | 173.109 | 39.439 | 57.085 |
| Cash & Equivalents | -0.001 | -0.001 | |||
| Short Term Investments | 31.285 | 25 | 20 | ||
| Total Receivables, Net | 23.912 | 44.013 | 19.232 | 24.03 | 11.259 |
| Accounts Receivable - Trade, Net | 23.912 | 44.013 | 19.232 | 24.03 | 11.259 |
| Total Inventory | 35.104 | 124.098 | 26.933 | 25.772 | 22.727 |
| Other Current Assets, Total | 79.112 | 71.079 | 57.868 | 14.921 | 14.902 |
| Total Assets | 621.344 | 817.352 | 449.164 | 264.723 | 229.907 |
| Property/Plant/Equipment, Total - Net | 154.038 | 173.83 | 78.153 | 69.337 | 37.997 |
| Property/Plant/Equipment, Total - Gross | 221.187 | 215.283 | 111.31 | 100.5 | 75.012 |
| Accumulated Depreciation, Total | -67.148 | -41.453 | -33.156 | -31.163 | -37.015 |
| Intangibles, Net | 28.711 | 32.7 | 35.409 | 41.813 | 44.891 |
| Other Long Term Assets, Total | 13.935 | 22.866 | 25.045 | 22.148 | 19.925 |
| Total Current Liabilities | 277.392 | 368.979 | 175.87 | 41.3 | 42.944 |
| Accounts Payable | 14.505 | 16.035 | 24.898 | 8.868 | 9.175 |
| Accrued Expenses | 42.724 | 69.333 | 24.479 | 18.323 | 12.793 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 36.991 | 10.242 | 9.684 | 4.307 | 17.529 |
| Other Current Liabilities, Total | 183.172 | 273.369 | 116.809 | 9.802 | 3.447 |
| Total Liabilities | 401.547 | 646.771 | 371.742 | 129.57 | 86.72 |
| Total Long Term Debt | 115.39 | 104.413 | 95.767 | 80.909 | 40.07 |
| Long Term Debt | 87.227 | 50.726 | 46.375 | 24.317 | 14.272 |
| Capital Lease Obligations | 28.163 | 53.687 | 49.392 | 56.592 | 25.798 |
| Deferred Income Tax | 0.694 | 1.29 | 0.412 | ||
| Other Liabilities, Total | 8.071 | 172.089 | 99.693 | 7.361 | 3.706 |
| Total Equity | 219.797 | 170.581 | 77.422 | 135.153 | 143.187 |
| Common Stock | 20.755 | 15.786 | 13.646 | 13.642 | 13.638 |
| Additional Paid-In Capital | 594.043 | 409.258 | 244.984 | 297.732 | 297.72 |
| Retained Earnings (Accumulated Deficit) | -389.315 | -248.671 | -177.835 | -170.272 | -161.559 |
| Treasury Stock - Common | -0.645 | -0.645 | -0.898 | -1.112 | -1.133 |
| Other Equity, Total | -5.041 | -5.147 | -2.475 | -4.837 | -5.479 |
| Total Liabilities & Shareholders’ Equity | 621.344 | 817.352 | 449.164 | 264.723 | 229.907 |
| Total Common Shares Outstanding | 138.223 | 105.115 | 90.8242 | 90.8195 | 90.7935 |
| Total Preferred Shares Outstanding | 0.02051 | 17.8367 | 17.8367 | 17.8367 | 17.8367 |
| Long Term Investments | 0 | 2.124 | 2.13 | 2.263 | 1.122 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Current Assets | 389.329 | 424.66 | 476.535 | 503.776 | 545.021 |
| Cash and Short Term Investments | 254.485 | 286.532 | 261.042 | 336.177 | 311.264 |
| Cash & Equivalents | 254.485 | -0.001 | 261.042 | 311.264 | |
| Total Receivables, Net | 27.018 | 23.912 | 57.732 | 16.251 | 25.061 |
| Accounts Receivable - Trade, Net | 27.018 | 23.912 | 57.732 | 16.251 | 25.061 |
| Total Inventory | 38.999 | 35.104 | 96.462 | 95.201 | 139.725 |
| Other Current Assets, Total | 68.827 | 79.112 | 61.299 | 56.147 | 68.971 |
| Total Assets | 590 | 621.344 | 698.083 | 725.105 | 777.711 |
| Property/Plant/Equipment, Total - Net | 158.039 | 154.038 | 170.659 | 169.992 | 175.98 |
| Intangibles, Net | 27.896 | 28.711 | 29.652 | 30.714 | 31.765 |
| Long Term Investments | 0 | 0 | 0 | 2.124 | |
| Other Long Term Assets, Total | 14.736 | 13.935 | 21.237 | 20.623 | 22.821 |
| Total Current Liabilities | 263.26 | 277.392 | 374.211 | 436.128 | 363.257 |
| Payable/Accrued | 33.52 | 41.491 | 74.973 | 83.704 | 66.268 |
| Accrued Expenses | 15.875 | 15.738 | 16.036 | 15.199 | 19.838 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 39.944 | 36.991 | 15.612 | 14.532 | 14.852 |
| Other Current Liabilities, Total | 173.921 | 183.172 | 267.59 | 322.693 | 262.299 |
| Total Liabilities | 385.217 | 401.547 | 533.1 | 631.85 | 629.305 |
| Total Long Term Debt | 112.784 | 115.39 | 146.007 | 118.989 | 100.668 |
| Long Term Debt | 83.228 | 87.227 | 93.364 | 67.058 | 48.005 |
| Capital Lease Obligations | 29.556 | 28.163 | 52.643 | 51.931 | 52.663 |
| Deferred Income Tax | 1.057 | 0.694 | 1.784 | 1.978 | 1.28 |
| Other Liabilities, Total | 8.116 | 8.071 | 11.098 | 74.755 | 164.1 |
| Total Equity | 204.783 | 219.797 | 164.983 | 93.255 | 148.406 |
| Common Stock | 20.752 | 20.755 | 17.603 | 17.603 | 16.17 |
| Additional Paid-In Capital | 594.043 | 594.043 | 501.638 | 501.638 | 412.799 |
| Retained Earnings (Accumulated Deficit) | -410.011 | -389.315 | -354.258 | -419.795 | -280.563 |
| Other Equity, Total | -0.001 | -5.041 | -5.546 | ||
| Total Liabilities & Shareholders’ Equity | 590 | 621.344 | 698.083 | 725.105 | 777.711 |
| Total Common Shares Outstanding | 138.223 | 138.223 | 117.276 | 117.276 | 107.727 |
| Total Preferred Shares Outstanding | 0.02051 | 0.02051 | 17.8367 | 17.8367 | |
| Cash | 286.533 | 336.177 | |||
| Short Term Investments | |||||
| Treasury Stock - Common | -0.645 | -0.645 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -143.279 | -73.425 | -64.393 | -1.744 | 3.264 |
| Cash From Operating Activities | -242.445 | 76.945 | 137.779 | 5.529 | 16.306 |
| Cash From Operating Activities | 21.036 | 14.281 | 9.799 | 8.532 | 6.828 |
| Non-Cash Items | -126.058 | 101.55 | 116.613 | 7.769 | 3.534 |
| Cash Taxes Paid | 0.154 | 1.631 | 2.021 | 2.346 | 1.273 |
| Cash Interest Paid | 9.211 | 8.417 | 4.711 | 2.621 | 4.165 |
| Changes in Working Capital | 5.856 | 34.539 | 75.76 | -9.028 | 2.68 |
| Cash From Investing Activities | -29.054 | -93.116 | -19.34 | -10.685 | -2.917 |
| Capital Expenditures | -29.322 | -93.171 | -19.471 | -10.884 | -3.171 |
| Other Investing Cash Flow Items, Total | 0.268 | 0.055 | 0.131 | 0.199 | 0.254 |
| Cash From Financing Activities | 215.116 | 154.504 | 21.74 | -7.696 | 30.945 |
| Financing Cash Flow Items | -9.211 | -8.417 | -4.71 | -2.621 | -4.165 |
| Issuance (Retirement) of Stock, Net | 189.837 | 166.823 | 0.29 | -2.463 | 49.263 |
| Issuance (Retirement) of Debt, Net | 34.49 | -3.902 | 26.16 | -2.612 | -14.153 |
| Foreign Exchange Effects | -0.828 | 3.96 | -0.183 | 0.207 | -0.795 |
| Net Change in Cash | -57.211 | 142.293 | 139.996 | -12.645 | 43.539 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -18.127 | -143.279 | -99.075 | -171.493 | -26.041 |
| Cash From Operating Activities | -24.326 | -242.445 | -186.562 | -100.18 | -26.806 |
| Non-Cash Items | 8.438 | -126.058 | 17.784 | -5.481 | -6.922 |
| Cash Taxes Paid | 0.433 | 0.154 | 1.082 | 0.818 | 0.318 |
| Cash Interest Paid | 2.689 | 9.211 | 6.544 | 4.054 | 1.909 |
| Changes in Working Capital | -14.637 | 5.856 | -105.271 | 65.641 | 6.157 |
| Cash From Investing Activities | -3.561 | -29.054 | -22.483 | -15.994 | -9.447 |
| Capital Expenditures | -3.814 | -29.322 | -22.541 | -16.028 | -9.461 |
| Other Investing Cash Flow Items, Total | 0.253 | 0.268 | 0.058 | 0.034 | 0.014 |
| Cash From Financing Activities | -3.816 | 215.116 | 121.631 | 105.006 | 0.982 |
| Financing Cash Flow Items | -2.689 | -9.211 | -6.544 | -4.054 | -1.909 |
| Issuance (Retirement) of Stock, Net | -0.194 | 189.837 | 93.998 | 94.308 | 3.726 |
| Issuance (Retirement) of Debt, Net | -0.933 | 34.49 | 34.177 | 14.752 | -0.835 |
| Foreign Exchange Effects | -0.344 | -0.828 | 1.814 | 0.751 | -0.107 |
| Net Change in Cash | -32.047 | -57.211 | -85.6 | -10.417 | -35.378 |
| Cash From Operating Activities | 21.036 | 11.153 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Valneva SE Company profile
About Valneva SE
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.
Financial summary
BRIEF: For the six months ended 30 June 2021, Valneva SE revenues decreased 1% to EUR47.5M. Net loss applicable to common stockholders increased from EUR25.6M to EUR86.4M. Revenues reflect Commercialized Vaccines segment decrease of 22% to EUR31.8M, Canada segment decrease of 75% to EUR2M, United Kingdom segment decrease of 75% to EUR1.1M, Europe excluding France segment decrease of 42% to EUR4.2M.
Equity composition
07/2010, Rights Issue, 2 new shares for every 5 shares held @ EUR 5.06 (Factor: 1.12817). 6/2013, Rights Issue, 5 new shares for every 13 shares held @ EUR2.65 (Factor: 1.11881). 1/2015, Rights Issue, 11 new shares for every 34 shares held @ EUR2.47 (Factor: 1.10896).
| Industry: | Biotechnology & Medical Research (NEC) |
6 rue Alain Bombard
SAINT-HERBLAIN
PAYS DE LA LOIRE 44800
FR
Income Statement
- Annual
- Quarterly
News
How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com